Skip to main content

2 Result(s)

within Ladislav Pazdera Remove this filter

and

  1. Article

    Open Access

    Capsaicin 8% patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy: a randomised, 52-week, open-label, safety study

    This 52-week study evaluated the long-term safety and tolerability of capsaicin 8% w/w (179 mg) patch repeat treatment plus standard of care (SOC) versus SOC alone in painful diabetic peripheral neuropathy (PD...

    Aaron I. Vinik, Serge Perrot, Etta J. Vinik, Ladislav Pazdera… in BMC Neurology (2016)

    Download PDF (1340 KB) View Article

  2. Article

    Open Access

    Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study

    Eslicarbazepine acetate (ESL, Aptiom®) is a once-daily (QD) anticonvulsant, approved as adjunctive treatment of partial-onset seizures (POS). It is extensively converted after oral administration to eslicarbaz...

    Mercedes P Jacobson, Ladislav Pazdera, Perminder Bhatia, Todd Grinnell… in BMC Neurology (2015)

    Download PDF (868 KB) View Article